NCT04471610View on ClinicalTrials.gov

Point Of Care With Serial NT-proBNP Measurement in Patients With Acute Decompensation of Heart Failure

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

January 23, 2018

Primary Completion Date

May 20, 2020

Study Completion Date

May 20, 2020

Conditions
Acute Decompensated Heart Failure
Interventions
OTHER

Serial measurements of NT-pro BNP, potassium, sodium, and creatinine every second business day

Serial measurements of NT-proBNP, sodium, potassium, and creatinine in the NT-proBNP-group vs. no serial measurements in control group. In the intervention group the body weight, vital parameters, therapy changes and adverse events are documented the above mention serial measurement every second business day.

Trial Locations (1)

4410

Cantonal Hospital Baselland Liestal, Liestal

All Listed Sponsors
lead

Prof. Dr. Jörg Leuppi

OTHER

NCT04471610 - Point Of Care With Serial NT-proBNP Measurement in Patients With Acute Decompensation of Heart Failure | Biotech Hunter | Biotech Hunter